Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes. [PDF]
CureusAlsayed O, Jarai MZ, Khan S, Sandal M.
europepmc +1 more source
Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis. [PDF]
Front Endocrinol (Lausanne)Santos-Pereira M +4 more
europepmc +1 more source
Rise or fall? Reconciling contested directions in human gut hormone aging. [PDF]
Front Endocrinol (Lausanne)Mavrych V, Shypilova I, Bolgova O.
europepmc +1 more source
Structured Exercise During and After Incretin-Based Pharmacotherapy Discontinuation: A Narrative Review of Mechanisms, Evidence, and Prescription Guidance. [PDF]
Healthcare (Basel)Zeigler Z +5 more
europepmc +1 more source
Correction: Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists. [PDF]
Cardiovasc ToxicolKhatami S +4 more
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists and Dual Incretin Therapies Across HFpEF and Cardiovascular Outcomes Trials in Patients with Obesity. [PDF]
Medicina (Kaunas)Belančić A +4 more
europepmc +1 more source
Weight management in cardiology practice: challenges and opportunities. [PDF]
Neth Heart JLeening MJG, Martens FMAC, Hemels MEW.
europepmc +1 more source
Medical nutrition therapy in incretin-treated obesity-related heart failure with preserved ejection fraction. [PDF]
Front NutrMing Q, Li Z.
europepmc +1 more source